
Forward v. Biogen: Biogen Prevails in MS Drug Patent Appeal in Federal Circuit
Continue reading
By Nathan Nima Shamtoub - Edited by Phebe Hong
Posted on November 05, 2018
FWP IP ApS v. Biogen MA, Inc., 2018 U.S. App. LEXIS 29943 (Fed. Cir. Oct. 24, 2018), opinion hosted by Court of Appeals for the Federal Circuit. On October 24, 2018, the Federal Circuit Court affirmed a Patent Trial and Appeal Board ("PTAB") decision that determined FWP IP ApS ("Forward") was not entitled to a patent on a multiple sclerosis...
Continue reading